By Karen Roman HF Foods Group Inc. (Nasdaq: HFFG) said fourth quarter net revenue increased 8.7% to $305.3 million compared to $280.9 million in the year prior. Quarterly adjusted EBITDA rose 39.4% to $14.5 million in comparison to $10.4 million,...

By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) announced it finished the placement of NPM-115, its GLP-1 (exenatide) implant, in the first-in-human clinical trial of its kind. The company also said it achieved full enrollment for this study, which targets...

By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said it expects to spin off Cortigent, Inc., its brain implant devices division, as an independent publicly-traded company. Vivani aims to create two companies focused on driving long term value creation in...

By Karen Roman Grove Collaborative Holdings, Inc. (NYSE: GROV) said annual adjusted EBITDA was $1.3 million, increasing $10.5 million year-over-year. Operating cash flow for Q4 was $0.3 million, making it the third consecutive quarter with positive results, it said. Grove...

By Karen Roman Biopharmaceutical company Medera Inc. said it finished patient dosing in the trial of SRD-001, its gene therapy candidate for heart failure with reduced ejection fraction. Additionally, Medera and Keen Vision Acquisition Corporation (Nasdaq: KVAC) announced they had...

By Daniella Parra Kohl’s Corporation (NYSE: KSS) said net sales fell 9.4% and 7.2% for both fourth-quarter and fiscal year 2024. The company’s diluted EPS for the fourth quarter was $0.43 ($0.95 adjusted), while full-year diluted EPS was $0.98 ($1.50...

By Karen Roman The ONE Group Hospitality, Inc. (Nasdaq: STKS) said fourth quarter revenue increased 146.7% to $221.9 million from $89.9 million and operating income rose 158.9% to $12.8 million from $4.9 million. The company opened six new restaurants in...

By Daniella Parra Potbelly Corp. (Nasdaq: PBPB) said its average weekly sales increased 1.1% to $25,230 and company-operated same-store sales in the fourth quarter increased 0.3%. Total revenues decreased 7.3% while adjusted EBITDA increased 30.0% to $9.7 million, they said....

By Karen Roman a.k.a. Brands Holding Corp. (NYSE: AKA) said fourth quarter net sales increased 6.8% to $159 million, compared to $148.9 million the year prior. Adjusted EBITDA was $6.2 million, or 3.9% of net sales, in contrast to $1.3...

By Daniella Parra Ascentage Pharma (NASDAQ: AAPG; HKEX) said that its drug Olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, and has been approved for certain chronic myeloid leukemia (CML) indications and included in China’s National Reimbursement Drug List. Olverembatinib,...